| Product Name |
Elagolix Sodium Inhouse Impurity 15 / 5-bromo-1-(2-fluoro-6-(trifluoromethyl)benzyl)-4-hydroxy-6-methylpyrimidin-2(1H)-one
|
| Product Category |
Impurities, Intermediates |
| Sub-Category |
Pharmaceutical Standards, Fine Chemicals, Aromatics, Amines |
| CAS No |
830346-48-0 |
| Catalog Number |
GS.07.ELA.45N |
| Chemical Name/Synonyms |
5-bromo-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methylpyrimidine-2,4(1H,3H)-dione;5-bromo-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methylpyrimidine-2,4-dione |
| Molecular Weight |
381.12 |
| Molecular Formula |
C13H9BrF4N2O2 |
| Purity |
NLT 95 % |
| Appearance |
White to Off-White Solid |
| Solubility |
Chloroform, DMSO & Methanol |
| Applications |
5-Bromo-1-[2-Fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4(1H,3H)-dione is an intermediate in the synthesis of Elagolix, a gonadotropin-releasing hormone antagonist (GnRH) used in the treatment of endometriosis. |
| Inventory Status |
QC Pending
|
